Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak

Official Title

Brief Summary

In the context of quarantine with COVID-19, we wish to study the experience and psychological impact in adult patients living with osteoporosis.

Status

Completed

Conditions

SARS-COV2

Osteoporosis

Interventions

Other: questionnaire assesment

questionnaire assesment

Eligibility Criteria

Inclusion Criteria:

- Patient with osteoporosis

- Patient in confinement

- Patient with sufficient understanding of the French language

Exclusion Criteria:

- Non adult patient

- patient without quarantine

Eligibility Gender

All

Eligibility Age

Minimum: 18 Years ~ Maximum: N/A

Countries

France

Locations

Hopital Roger Salengro, CHU Lille
Lille, France

Investigators

Bernard Cortet, MD,PhD, Principal Investigator
University Hospital, Lille

NCT Number

NCT04351633

Keywords

Psychological impact

Covid-19

MeSH Terms

COVID-19

Osteoporosis

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

navigator@reaganudall.org

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA